Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.02 HKD | +15.27% | +14.83% | -54.52% |
02:49pm | Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates | MT |
06-03 | Alphamab Presents Results of Phase 1/2 China Trial for Tumor Drug in US Oncology Meeting | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.52% | 324M | |
+46.19% | 55.7B | |
+40.15% | 39.91B | |
-6.14% | 39.57B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
+28.38% | 12.17B | |
+24.18% | 12.12B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- 9966 Stock
- News Alphamab Oncology
- Nomura Adjusts Alphamab Oncology's Price Target to HK$13.22 From HK$13.89, Keeps at Buy